RPL20B Antibody

Biological Role of RPL20B

RPL20B is a paralog of RPL20A in Saccharomyces cerevisiae, with both proteins contributing to ribosome assembly. Despite equivalent mRNA levels of RPL20A and RPL20B in wild-type yeast, deletion mutants exhibit paralog-specific effects:

• RPL20B deletion (rpl20bΔ) reduces 60S ribosomal subunit levels and extends replicative lifespan compared to rpl20aΔ mutants .

• Functional disparities arise from differences in protein stability or activity rather than transcriptional regulation .

Antibody Applications in Research

RPL20B antibodies are utilized to explore:

• Ribosome assembly dynamics: Tracking RPL20B incorporation into pre-60S particles .

• Paralog-specific functions: Differentiating roles of RPL20A and RPL20B in lifespan regulation .

• Disease associations: While direct links to human pathologies are understudied, ribosomal proteins like RPL22 and RPL5 are implicated in cancers and immune disorders, suggesting potential analogous roles for RPL20B .

Validation and Characterization

Antibody specificity is critical. Best practices include:

These methods align with the "five pillars" of antibody validation .

Research Findings

• Functional divergence: RPL20B’s role in lifespan extension is linked to reduced 60S subunit availability, which may delay aging via translational regulation .

• Paralog compensation: RPL20A and RPL20B exhibit incomplete functional redundancy, as seen in differential rescue capabilities .

• Broader implications: Ribosomal protein antibodies (e.g., RPL22) are used to study hematopoiesis, cancer, and immune tolerance , providing a framework for RPL20B research.

Future Directions

• Mechanistic studies: Clarify how RPL20B depletion alters ribosome stoichiometry and stress responses.

• Disease models: Explore connections to ribosomopathies or cancers, as seen with RPL22 .

• Antibody optimization: Adopt recombinant formats to improve specificity .